The CDC announced $215 million in first-year funding as part of a five-year, $1.1 billion investment to advance precision medicine and cancer research.
Source: James Gathany, Centers for Disease Control and Prevention
- The Centers for Disease Control and Prevention (CDC) announced $215 million in funding awards for 86 recipients under three national cancer programs: the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries.
The funding is part of a five-year, $1.1 billion investment in cancer prevention included in President Biden’s Cancer Moonshot, the initiative that aims to “end cancer as we know it” by reducing the death rate by at least 50 percent over the next 25 years. The Cancer Moonshot also focuses on improving the experience of those who are living with cancer, cancer survivors, and their families.
“Today we know cancer as a disease that we often diagnose too late, but thankfully we have a few ways to prevent it and tackle stark inequities across races, regions, and resources,” said the Department of Health and Human Services Secretary Xavier Becerra in the press release. “This funding is a critical investment in support of President Biden’s Cancer Moonshot initiative and our efforts to help ensure that everyone in the United States equitably benefits from the tools we have to detect and diagnose cancer.”
By 